Pharmafile Logo

Research Partnership’s MedTech Division appoints two Directors

May 14, 2021 | Medtech, News, Staff announcement 

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

We are delighted to announce that Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Chris has over 27 years’ experience in healthcare research and consulting and his peers acknowledge him to be a strategic thinker with a demonstrated ability to leverage primary and secondary market research, connecting disparate pieces of information to form a clear picture. He most recently served as Vice President, Strategic Research Services for the KJT Group and his other professional experiences include roles with a product design consultancy, independent moderating, Becton Dickinson and with J&J’s Ethicon Endo-Surgery.

Andrew is a seasoned market research professional with over 13 years’ experience in healthcare research and consulting. He has experience of working across a broad range of therapy areas and devices and has previously focused on both quantitative and qualitative research. Andrew has previously worked at InStar Research and Medex Research.

Head of MedTech Division, Sabera Hyderally said of the appointment, “I am delighted to welcome both Chris and Andrew to the MedTech division. They bring a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with researchers of their calibre as we continue our tremendous growth globally.”

Founding Director Mary Assimakopoulos added, “We are very pleased that both Chris and Andrew have chosen to join Research Partnership. They have both previously worked with a range of MedTech clients and bring a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.